Roblox has announced Build, a new AI creation tool that lets anyone turn a text prompt into a basic game directly within the ...

How to Choose the Right One." This guide compares leading AI twin generators and AI clone video tools that turn a single photo ...

If you've spent any time testing AI video tools, you've probably noticed a pattern: most of them are built for short bursts.

The former majority owner of TikTok has quietly continued to court filmmakers, independent artists and executives who are ...

Generating $7,500 a month in dividend income means producing $90,000 a year from a portfolio without needing to regularly sell principal, though the underlying portfolio value can still fluctuate. For ...

Google AI Studio lets users test Gemini models, build apps, generate media, and export code. Here’s what it does, costs, and where it falls short. For years, building software meant setting up local ...

HandBrake is a free batch video converter software for Windows. After launching the HandBrake, you will see two options, Folder (batch scan) and File. If you have stored videos for conversion in ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Microsoft is rolling out new Windows 11 Insider Preview builds that improve security and performance during batch file or CMD script execution. As Microsoft explained today, IT administrators can now ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...